Cargando…
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiprolifera...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343727/ https://www.ncbi.nlm.nih.gov/pubmed/37446609 http://dx.doi.org/10.3390/molecules28134947 |
_version_ | 1785072805299093504 |
---|---|
author | Liu, Xiongxiong Zhao, Ting Shi, Zheng Hu, Cuilan Li, Qiang Sun, Chao |
author_facet | Liu, Xiongxiong Zhao, Ting Shi, Zheng Hu, Cuilan Li, Qiang Sun, Chao |
author_sort | Liu, Xiongxiong |
collection | PubMed |
description | Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC(50) of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research. |
format | Online Article Text |
id | pubmed-10343727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103437272023-07-14 Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells Liu, Xiongxiong Zhao, Ting Shi, Zheng Hu, Cuilan Li, Qiang Sun, Chao Molecules Article Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC(50) of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research. MDPI 2023-06-23 /pmc/articles/PMC10343727/ /pubmed/37446609 http://dx.doi.org/10.3390/molecules28134947 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Xiongxiong Zhao, Ting Shi, Zheng Hu, Cuilan Li, Qiang Sun, Chao Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title | Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title_full | Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title_fullStr | Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title_full_unstemmed | Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title_short | Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells |
title_sort | synergism antiproliferative effects of apigenin and naringenin in nsclc cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343727/ https://www.ncbi.nlm.nih.gov/pubmed/37446609 http://dx.doi.org/10.3390/molecules28134947 |
work_keys_str_mv | AT liuxiongxiong synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells AT zhaoting synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells AT shizheng synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells AT hucuilan synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells AT liqiang synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells AT sunchao synergismantiproliferativeeffectsofapigeninandnaringenininnsclccells |